Proactive Investors - Run By Investors For Investors
Why invest in CTAG?
CloudTag Inc: DEEP DIVE

CloudTag pledges to return after delisting from Aim

The company, which historically got most of its funding from long-term private investors, will continue as a private company.
CloudTag app
OVERVIEW: CTAG The Big Picture
The directors believe CloudTag will launch its first product within the next 12 months

CloudTag Inc (LON:CTAG) said it would seek a return to listed status in due course after its shares were delisted from Aim.

The company’s nominated adviser (Nomad) tendered its resignation a month ago and the company has not appointed a replacement, which means under Aim’s rules it cannot retain its listing.

The company will continue as a private company, it said in its full-year results statement.

The developer of wearable devices that monitor health, wellbeing and fitness is still in the pre-revenue stage, and in a year of heavy research & development plus preparation for the launch of its flagship product, the loss before tax ballooned to £8.32mln from £1.99mln the year before.

Net cash outflow from operating activities after taxation was £4.38mln in the year to 30 September 2016, compared to £1.28mln the year before.

At the end of the financial year the group held cash balances of £30,000, but since then it has renewed its £1.25mln convertible loan note draw-down facility and raised a further £4.5mln in funding from the issue of loan notes to L1 Capital Global Opportunities Master Fund, plus £516,000 from the issue of shares results from the exercising of options and warrants.

Unless it starts to generate revenue, the group will need to raise further funds over the next 12 months, which may prove difficult as an unlisted company, but the directors believe CloudTag will launch its first product within the next 12 months, thereby generating revenue.

The directors are continuing to explore alternative sources of finance and have prepared the financial statements on the going concern basis on the assumption that such sources of finance will be found to enable the development of the product to continue.

The majority of CloudTag’s fundraising has come from long term private investors and the board is confident that the company will continue to receive the support of these individuals.

“The board is aware that there has been investor frustration that the company did not release its product to the retail market during the year,” revealed chief executive officer Amit Ben-Haim. 

“The company is determined to ensure that the product's performance marks a step change to other available devices,” he said, adding that the company has many proprietary algorithms and has filed patent applications, design registrations and design patents to protect the intellectual property developed by the group.

The company is up against some big players in the wearable health monitor market and its plan is to seek our niche areas where its technology will stand out from the established operators.

“This work has identified a number of B2C [business-to-consumer] openings in the wellness market and prospects in the automotive and e-textile industries,” Ben-Haim said.

View full CTAG profile View Profile

CloudTag Inc Timeline

January 17 2017

Related Articles

Male model
July 09 2018
Clothes maketh the man ... and the chances are, those clothes were bought from a website that uses ATTRQT's technology
Keywords Studio
June 17 2019
Keywords has a buy-and-build strategy and has been expanding rapidly since its first acquisition in 2014.
June 17 2019
Signs FPGA Smartnic deal with Chinese firm FiberHome

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use